Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Forensic Toxicology
Published in: Forensic Toxicology 2/2018

01-07-2018 | Original Article

Identification and characterization of the new psychoactive substance 3-fluoroethamphetamine in seized material

Authors: Ángela Yanini, Sergio Armenta, Francesc A. Esteve-Turrillas, Nieves Galipienso, Miguel de la Guardia

Published in: Forensic Toxicology | Issue 2/2018

Login to get access

Abstract

Purpose

An amphetamine-type new psychoactive substance was identified in a fine white yellowish powder from a seizure control held in Spain in July 2017.

Methods

Seized sample was deeply characterized by standard and high-performance analytical techniques like attenuated total reflectance-Fourier-transform infrared spectroscopy, gas chromatography–electron ionization–mass spectrometry, high-resolution mass spectrometry, nuclear magnetic resonance spectroscopy, and ion mobility spectrometry.

Results

The seized sample was identified as 3-fluoroethamphetamine hydrochloride. To our knowledge this is the first report dealing with identification and characterization of 3-fluoroethamphetamine.

Conclusions

Characterization data were compiled in order to provide the scientific community with sufficient information to allow a quick and accurate determination of 3-fluoroethamphetamine in future seizures.
Appendix
Available only for authorised users
Literature
1.
Carroll I, Lewin AH, Mascarella SW, Seltzman HH, Reddy PA (2012) Designer drugs: a medicinal chemistry perspective. Ann NY Acad Sci 1248:18–38CrossRefPubMed
2.
3.
Sitte HH, Freissmuth M (2015) Amphetamines, new psychoactive drugs and the monoamine transporter cycle. Trends Pharmacol Sci 36:41–50CrossRefPubMed
4.
5.
Rösner P, Quednow B, Girreser U, Junge T (2005) Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues (designer drugs). Forensic Sci Int 148:143–156CrossRefPubMed
6.
Tessel RE, Woods JH (1974) Structural relationship between meta-substituted N-ethylamphetamines and self-administration in rhesus monkeys. Pharmacologist 16:142
7.
Tessel RE, Woods JH, Counsell RE, Lu M (1975) Structure-activity relationships between meta-substituted N-ethylamphetamines and locomotor activity in mice. J Pharmacol Exp Ther 192:310–318PubMed
8.
Tessel RE, Woods JH (1978) Meta substituted N-ethylamphetamine self injection responding in the rhesus monkey: structure-activity relationships. J Pharmacol Exp Ther 205:274–281PubMed
9.
10.
11.
12.
13.
Maurer HH, Pfleger K, Weber AA (2007) Mass spectral and GC data of drugs, poisons, pesticides, pollutants, and their metabolites, 3rd edn. Wiley, Hoboken
14.
Heacock RA, Marion L (1956) The infrared spectra of secondary amines and their salts. Can J Chem 34:1782–1795CrossRef
15.
Conley RT (1972) Infrared spectroscopy, 2nd edn. Allyn and Bacon Inc., Boston
16.
Sachs S, Woo F (2007) A detailed mechanistic fragmentation analysis of methamphetamine and select regioisomers by GC/MS. J Forensic Sci 52:308–319CrossRefPubMed
17.
18.
Keller T, Schneider A, Tutsch-Bauer E, Jaspers J, Aderjan R, Skopp G (1999) Ion mobility spectrometry for the detection of drugs in case of forensic and criminalistic relevance. Int J Ion Mobility Spectrom 2:22–34
19.
Miki A, Keller T, Regenscheit P, Dirnhofer R, Tatsuno M, Katagi M, Nishikawa M, Tsuchihashi H (1997) Application of ion mobility spectrometry to the rapid screening of methamphetamine incorporated in hair. J Chromatogr B 692:319–328CrossRef
20.
21.
Armenta S, Garrigues S, de la Guardia M, Brassier J, Alcalà M, Blanco M, Perez-Alfonso C, Galipienso N (2015) Detection and characterization of emerging psychoactive substances by ion mobility spectrometry. Drug Test Anal 7:280–289CrossRefPubMed
Metadata
Title
Identification and characterization of the new psychoactive substance 3-fluoroethamphetamine in seized material
Authors
Ángela Yanini
Sergio Armenta
Francesc A. Esteve-Turrillas
Nieves Galipienso
Miguel de la Guardia
Publication date
01-07-2018
Publisher
Springer Japan
Published in
Forensic Toxicology / Issue 2/2018
Print ISSN: 1860-8965
Electronic ISSN: 1860-8973
DOI
https://doi.org/10.1007/s11419-018-0416-y

Other articles of this Issue 2/2018

Forensic Toxicology 2/2018 Go to the issue

Review Article

Diphenidine: a dissociative NPS makes an entrance on the drug scene

Original Article

The internal standard diquat-d4 causes errors in diquat analysis by LC–MS/MS

Original Article

Use of hepatocytes isolated from a liver-humanized mouse for studies on the metabolism of drugs: application to the metabolism of fentanyl and acetylfentanyl

Original Article

In vitro metabolism of synthetic cannabinoid AM1220 by human liver microsomes and Cunninghamella elegans using liquid chromatography coupled with high resolution mass spectrometry

Original Article

MDMB-CHMICA induces thrashing behavior, bradycardia, and slow pressor response in a CB1- and CB2-receptor-dependent manner in conscious rats

Original Article

Metabolism of α-PHP and α-PHPP in humans and the effects of alkyl chain lengths on the metabolism of α-pyrrolidinophenone-type designer drugs